Body shop: First repair of single-gene mutation in human embryos

August 07, 2017 – Humans become reparable like a broken car in the body shop: For the first time, scientists have corrected a disease-causing mutation in early stage human embryos with gene editing (or genome editing). By doing so, researchers  repaired in these early stage human embryos the genetic/molecular defect

Read more ›

Share
Posted in Allelic Variant, Genetic Predisposition, Genetic Susceptibility, In The Press, Personalized Medicine, Rare Diseases, Thasso Post, Theragenomic Medicine
Tags: , , , , , , , , ,

Enasidenib (Idhifa): Targeted treatment for relapsed or refractory AML

August 02, 2017 – This is another cornerstone in the fight against acute myeloid leukemia (AML): The American Food and Drug Administration (FDA) just approved Enasidenib (Idhifa) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. The drug is

Read more ›

Share
Posted in Companion Test, Diagnostic, New Drug Approval, Personalized Medicine, Thasso Post, Theragenomic Medicine
Tags: , , , , , , , , , ,

Twin cities facing genetic disaster: Fumarase deficiency

August 03, 2017 – Fumarase deficiency is extremely rare – until around 1990 there had only been 13 diagnosed and identified cases worldwide. Fumarase deficiency is an autosomal recessive metabolic disorder characterized by a deficiency of the enzyme fumarate hydratase, which is indicated by a buildup of fumaric acid in the urine. With

Read more ›

Share
Posted in Allelic Variant, Genetic Background, Thasso Post, Theragenomic Medicine
Tags: , , , , , ,

Ashkenazi Jewish Women: Little-known Gene Mutations May Boost Breast Cancer Risk

July 27, 2017 – Jewish women of Ashkenazi descent may be at risk for additional genetic mutations that increase their risk of breast cancer, according to a new study just published in JAMA Oncology. Researchers from University of Washington in Seattle found that around 4 percent of Ashkenazi Jewish women without

Read more ›

Share
Posted in Allelic Variant, Genetic Predisposition, New Research, Personalized Medicine, Thasso Post, Theragenomic Medicine
Tags: , , , , , , , , , , , ,

Genetic Biomarker Tied to Suicide Risk in Schizophrenia

 July 18, 2017 – According to a new study just published in the Journal of  Psychiatric Research, a single-nucleotide polymorphism (SNP), rs300774, which previously had been identified as a marker for suicide in people with bipolar disorder (BD), also predicts suicide attempts in people with schizophrenia (SCZ) or schizoaffective disorder (SAD).

Read more ›

Share
Posted in Genetic Background, New Research, On The Horizon, Personalized Medicine, Thasso Post, Theragenomic Medicine
Tags: , , , , , , , , ,

Genetic Study Strengthens Causal Role of BMI in Heart Disease

July 07, 2017 – A new study analyzing genetic mutations predisposing to increased body-mass index (BMI) provides strong evidence that higher BMI plays a causal role in type 2 diabetes, hypertension, and coronary heart disease (CHD). The study results strongly suggest that BMI is causally related to increased risk of developing diabetes,

Read more ›

Share
Posted in Genetic Background, Genetic Predisposition, Personalized Medicine, Thasso Post, Theragenomic Medicine
Tags: , , , , , , ,

Asthma: An allelic variant of the PYHIN1 gene is unique to African Americans

July 04, 2017 – Asthma Gene Unique To African Americans. This has been the headline of an article in the Resppiratory/Asthma section of Medical News Today. According to an earlier study, researchers  have identified a new gene uniquely linked to asthma in African Americans, namely a variant of the gene

Read more ›

Share
Posted in Genetic Predisposition, New Research, Personalized Medicine, Thasso Post, Theragenomic Medicine
Tags: , , , , , , , , , ,

APP A673T carriers: Lower Aβ levels protective against Alzheimer’s Disease?

July 02, 2017 – The APP A673T allelic variant of the amyloid precursor protein (APP) gene which in earlier research has been shown to protect against Alzheimer’s Disease (AD) is associated with decreased levels of plasma amyloid β (Aβ), according to a new study just published in Annals of Neurology.

Read more ›

Share
Posted in Allelic Variant, Genetic Background, New Research, Personalized Medicine, Thasso Post, Theragenomic Medicine
Tags: , , , , ,

The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer

June 30, 2017 – The below citation from PubMed addresses an vey important issue associated with genetic testing in theragenomic and personalized medicine. It is the question if the genetic test used to stage, classify, or determine treatability of a disease with a given drug is accurate. Notably in the

Read more ›

Share
Posted in Companion Test, Diagnostic, Personalized Medicine, PubMed Entry, Thasso Post, Theragenomic Medicine
Tags: , , , , , , , ,

Sexual activity to boost brain power of the elderly

June 23, 2017 – According to a new study involving 73 people between 50 and 83 years of age, just published in The Journals of Gerontology, Series B: Psychological and Social Sciences, more frequent sexual activity can boost brain power (i.e., intellectual and mental abilities) in older adults. In simple tests,

Read more ›

Share
Posted in Genetic Background, In The Press, New Research, Thasso Post, Theragenomic Medicine
Tags: , , , , , ,

thasso: conditions

thasso post magazine

View my Flipboard Magazine.

follow thasso

Facebooktwittergoogle_pluslinkedinrssyoutubeby feather

subscribe to thasso post

By signing up, you agree to our Terms of Service and Privacy Policy.

thasso: categories

thasso: archives

thasso: tweets

thasso chat / comments

You must be a registered user to participate in this chat.